| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on December 2, 2002
Revised on January 12, 2004
Accepted on January 13, 2004
From the Microbiology and Tumor Biology Center (R.C., A.E., Y.C.) Karolinska Institutet, Stockholm, Sweden; Molecular/Cancer Biology Laboratory and Ludwig Institute for Cancer Research (H.K., K.A.), Haartman Institute and Helsinki University Central Hospital, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland; and Department of Cell and Molecular Biology (J.T.), Karolinska Institutet, Stockholm, Sweden.
* To whom correspondence should be addressed. E-mail: yihai.cao{at}mtc.ki.se.
Several endothelial growth factors induce both blood and lymphatic angiogenesis. However, a systematic comparative study of the impact of these factors on vascular morphology and function has been lacking. In this study, we report a quantitative analysis of the structure and macromolecular permeability of FGF-2-, VEGF-A-, and VEGF-C-induced blood and lymphatic vessels. Our results show that VEGF-A-stimulated formation of disorganized, nascent vasculatures as a result of fusion of blood capillaries into premature plexuses with only a few lymphatic vessels. Ultrastructural analysis revealed that VEGF-A-induced blood vessels contained high numbers of endothelial fenestrations that mediated high permeability to ferritin, whereas the FGF-2-induced blood vessels lacked vascular fenestrations and showed only little leakage of ferritin. VEGF-C induced approximately equal amounts of blood and lymphatic capillaries with endothelial fenestrations present only on blood capillaries, mediating a medium level of ferritin leakage into the perivascular space. No endothelial fenestrations were found in FGF-2-, VEGF-A-, or VEGF-C-induced lymphatic vessels. These findings highlight the structural and functional differences between blood and lymphatic vessels induced by FGF-2, VEGF-A, and VEGF-C. Such information is important to consider in development of novel therapeutic strategies using these angiogenic factors.
This article has been cited by other articles:
![]() |
W. P. Dunworth and K. M. Caron G Protein-Coupled Receptors as Potential Drug Targets for Lymphangiogenesis and Lymphatic Vascular Diseases Arterioscler Thromb Vasc Biol, May 1, 2009; 29(5): 650 - 656. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Satchell and F. Braet Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier Am J Physiol Renal Physiol, May 1, 2009; 296(5): F947 - F956. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Jin, K. Harada, S. Ohnishi, K. Yamahara, K. Kangawa, and N. Nagaya Adrenomedullin induces lymphangiogenesis and ameliorates secondary lymphoedema Cardiovasc Res, December 1, 2008; 80(3): 339 - 345. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cheng, H. Zhang, X. Yang, E. Tzima, K. L. Ewalt, P. Schimmel, and J. E. Faber Effect of mini-tyrosyl-tRNA synthetase on ischemic angiogenesis, leukocyte recruitment, and vascular permeability Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2008; 295(4): R1138 - R1146. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Foster, S. C. Slater, J. Seckley, D. Kerjaschki, D. O. Bates, P. W. Mathieson, and S. C. Satchell Vascular Endothelial Growth Factor-C, a Potential Paracrine Regulator of Glomerular Permeability, Increases Glomerular Endothelial Cell Monolayer Integrity and Intracellular Calcium Am. J. Pathol., October 1, 2008; 173(4): 938 - 948. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Rockson Diagnosis and Management of Lymphatic Vascular Disease J. Am. Coll. Cardiol., September 2, 2008; 52(10): 799 - 806. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Elias, J. Arbiser, B. E. Brown, H. Rossiter, M.-Q. Man, F. Cerimele, D. Crumrine, R. Gunathilake, E. H. Choi, Y. Uchida, et al. Epidermal Vascular Endothelial Growth Factor Production Is Required for Permeability Barrier Homeostasis, Dermal Angiogenesis, and the Development of Epidermal Hyperplasia: Implications for the Pathogenesis of Psoriasis Am. J. Pathol., September 1, 2008; 173(3): 689 - 699. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhan, D. Ou, X. Piao, S. W. Kim, Y. Liu, and J. Wang Dietary Arginine Supplementation Affects Microvascular Development in the Small Intestine of Early-Weaned Pigs J. Nutr., July 1, 2008; 138(7): 1304 - 1309. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zhang, R. Guo, Y. Lu, L. Zhao, Q. Zhou, E. M. Schwarz, J. Huang, D. Chen, Z.-G. Jin, B. F. Boyce, et al. VEGF-C, a Lymphatic Growth Factor, Is a RANKL Target Gene in Osteoclasts That Enhances Osteoclastic Bone Resorption through an Autocrine Mechanism J. Biol. Chem., May 9, 2008; 283(19): 13491 - 13499. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Benest, S. J. Harper, S. Y. Herttuala, K. Alitalo, and D. O. Bates VEGF-C induced angiogenesis preferentially occurs at a distance from lymphangiogenesis Cardiovasc Res, May 1, 2008; 78(2): 315 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Al-Dissi, D. M. Haines, B. Singh, and B. A. Kidney Immunohistochemical Expression of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor Associated with Tumor Cell Proliferation in Canine Cutaneous Squamous Cell Carcinomas and Trichoepitheliomas Vet. Pathol., November 1, 2007; 44(6): 823 - 830. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Lash, B. Schiessl, M. Kirkley, B. A. Innes, A. Cooper, R. F. Searle, S. C. Robson, and J. N. Bulmer Expression of angiogenic growth factors by uterine natural killer cells during early pregnancy J. Leukoc. Biol., September 1, 2006; 80(3): 572 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Cao, M. A. Bjorndahl, M. I. Gallego, S. Chen, P. Religa, A. J. Hansen, and Y. Cao Hepatocyte growth factor is a lymphangiogenic factor with an indirect mechanism of action Blood, May 1, 2006; 107(9): 3531 - 3536. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Ozerdem, K. Alitalo, P. Salven, and A. Li Contribution of Bone Marrow-Derived Pericyte Precursor Cells to Corneal Vasculogenesis Invest. Ophthalmol. Vis. Sci., October 1, 2005; 46(10): 3502 - 3506. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Amano, N. R. Hackett, S. Rafii, and R. G. Crystal Thrombopoietin Gene Transfer-Mediated Enhancement of Angiogenic Responses to Acute Ischemia Circ. Res., August 19, 2005; 97(4): 337 - 345. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Hallmann, N. Horn, M. Selg, O. Wendler, F. Pausch, and L. M. Sorokin Expression and Function of Laminins in the Embryonic and Mature Vasculature Physiol Rev, July 1, 2005; 85(3): 979 - 1000. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Silliman, D. R. Ambruso, and L. K. Boshkov Transfusion-related acute lung injury Blood, March 15, 2005; 105(6): 2266 - 2273. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tammela, B. Enholm, K. Alitalo, and K. Paavonen The biology of vascular endothelial growth factors Cardiovasc Res, February 15, 2005; 65(3): 550 - 563. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Manalo, A. Rowan, T. Lavoie, L. Natarajan, B. D. Kelly, S. Q. Ye, J. G. N. Garcia, and G. L. Semenza Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1 Blood, January 15, 2005; 105(2): 659 - 669. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mura, C. C. dos Santos, D. Stewart, and M. Liu Vascular endothelial growth factor and related molecules in acute lung injury J Appl Physiol, November 1, 2004; 97(5): 1605 - 1617. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Chang, G. Garcia-Cardena, F. Farnebo, M. Fannon, E. J. Chen, C. Butterfield, M. A. Moses, R. C. Mulligan, J. Folkman, and A. Kaipainen Dose-dependent response of FGF-2 for lymphangiogenesis PNAS, August 10, 2004; 101(32): 11658 - 11663. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |